Skip to Content Skip to Footer
Cynthia Jackevicius, BScPhm, PharmD, MSc, BCPS-AQ Cardiology, BCCP, FCSHP, FAHA, FCCP, FCCS, FACC

Cynthia Jackevicius, BScPhm, PharmD, MSc, BCPS-AQ Cardiology, BCCP, FCSHP, FAHA, FCCP, FCCS, FACC

Professor of Pharmacy Practice and Administration

College of Pharmacy

Phone: (909) 469-5527

  • Education

    Shenandoah University , Virginia

    MSc (Clin Epi)
    University of Toronto (Faculty of Medicine)

    Pharmacy Practice Residency
    Toronto General Hospital

    University of Toronto

  • Certification

    AQ Cardiology
    Board of Pharmaceutical Specialties

    Board Certified Cardiology Pharmacist

    Board of Pharmaceutical Specialties

  • Work Site

    VA Greater Los Angeles Healthcare System
    VA West Los Angeles Healthcare Center
    11301 Wilshire Blvd, Los Angeles CA 90073

    The clerkship is designed to provide various clinical experiences necessary to prepare students to become entry level practitioners. Students are involved with direct patient care activities, providing pharmaceutical care to patients with cardiology conditions. Students are expected to work with other health care professionals to assist with preventing and resolving patient's medication therapy problems. Students are required to present an evidence-based medicine journal club and complete a drug information project during the rotation.

  • Research Interest

    Her areas of research involve: quality of cardiovascular medication utilization and medical care, medication prescribing patterns, patient education and adherence, lipid lowering therapy, acute coronary syndromes (specifically, antithrombotic therapy), and gender bias in cardiovascular disease and medication use.

    Research Affiliation: Institute for Clinical Evaluative Sciences.

  • Publications

    Jackevicius CA, Ko DT. Medication copayment vouchers, adherence with antiplatelet therapy, and adverse cardiovascular events following myocardial infarction. JAMA 2019;321-37-9.

    Jackevicius CA, Tsakok M, Essebag V, Atzema C, Eisenberg MJ, Tu JV, Lu L, Rahme E, Humphries KH, Ho PM, Turakhia M, Behlouli H, Zhou L, Pilote L. Early nonpersistence with dabigatran and rivaroxaban in patients with atrial fibrillation. Heart 2017;103:1331-8.

    Jackevicius CA, Chou MM, Ross JS, Shah ND, Krumholz HM. Generic atorvastain and health care costs. N Engl J Med 2011: N Engl J Med 2012; 366:201-204

    Jackevicius CA, Tu JV, Ross JS, Ko DT, Krumholz HM. Use of ezetimibe in the United States and Canada. N Engl J Med 2008;358:1819-28.

    Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence post-acute myocardial infarction. Circulation 2008;117:1028-36.

    Jackevicius CA, Demers V, Melo M, Cox J, Rinfret S, Kalavrouziotis D, Johansen H, Behlouli H, Newman A, Tu JV, Pilote L. Cardiovascular outcomes after a change in prescription policy for clopidogrel. N Engl J Med 2008;359:1802-10.

    Jackevicius CA, Mamdani M, Tu JV. Adherence with statins in patients with and without acute coronary syndromes. J Amer Med Assoc 2002; 288:463-7.

    Jackevicius CA, Anderson GM, Leiter L, Tu JV. Use of the statins in patients after acute myocardial infarction: does evidence change practice? Arch Intern Med 2001;161:183-8.

    Further Publications:PubMed